Potassium orotate, tablets 500 mg 20 pcs
€9.77 €8.55
Pharmacotherapeutic group: metabolic agent. ATX code: A05BA The drug is potassium salt of orotic acid. Orotic acid is one of the precursors of pyrimidine nucleotides that are part of nucleic acids involved in the synthesis of protein molecules, so orotic acid salts are considered as substances of anabolic action and are used in disorders of protein metabolism for their stimulation.
Potassium orotate stimulates the synthesis of nucleic acids, albumin production in the liver, especially in conditions of prolonged hypoxia (oxygen deficiency), increases appetite, has diuretic (diuretic) and regenerating properties.
Pharmacokinetics
After oral administration 10 % of the ingested dose is absorbed in gastrointestinal tract. It is converted into orotidine-5-phosphate in the liver. It is excreted by the kidneys (30% as metabolites).
Indications
- In complex therapy as an adjuvant: In diseases of the liver and biliary tract caused by acute and chronic intoxications (except for organic lesions of the liver and biliary tract);
- as a result of malnutrition in children (alimentary and alimentary-infectious hypotrophy).
- in convalescence period after illness
- in chronic physical overstrain.
.
Active ingredient
Orotic acid
Composition
Active ingredient:
Potassium orotate. -500.0 mg
Excipients:
lactose monohydrate-165.0 mg
potato starch-55.0 mg
povidone K-17. – 22.5 mg
calcium stearate-7.5 mg
How to take, the dosage
Should be taken orally 1 hour before a meal or 4 hours after a meal.
Interaction
Astringents and coagulants can slightly reduce absorption of potassium orotate in the gastrointestinal tract.
Special Instructions
Attention to diet is advisable during treatment.
Ability to affect reaction time while driving or operating other machinery
The drug does not cause drowsiness and decrease psychomotor reaction speed.
The drug does not cause drowsiness and decrease psychomotor reaction speed.
Synopsis
Round, white, beveled, flat cylindrical tablets with a groove on one side.
Contraindications
Hypersensitivity to the drug components; acute and chronic organic liver disease (including cirrhosis); ascites (fluid accumulation in the abdominal cavity); urolithiasis; renal failure; children under 3 years of age.
Side effects
Potassium orotate is usually well tolerated.
Overdose
There are no data on overdose.
Weight | 0.100 kg |
---|---|
Shelf life | 4 years. After the expiration date indicated on the package, do not use. |
Conditions of storage | In a dry place at a temperature not exceeding 25 °С in the manufacturer's package. Keep out of reach of children. |
Manufacturer | Update PFC AO, Russia |
Medication form | pills |
Brand | Update PFC AO |
Related products
Buy Potassium orotate, tablets 500 mg 20 pcs with delivery to USA, UK, Europe and over 120 other countries.